Attending Physician
Associate Professor of Clinical Pediatrics, Keck School of Medicine of USC
  • Summary
  • Publications
  • Research
  • Locations

Dr. Winston Huh is a member of the Leukemia/Lymphoma Program within the Children's Center for Cancer and Blood Diseases. Following his residency and fellowship training at the University of Texas Southwestern Medical Center, Dr. Huh was a clinical faculty member in the Division of Pediatrics at the University of Texas MD Anderson Cancer Center from 2005 to 2018. At MD Anderson, Dr. Huh developed clinical interests in sarcomas, rare pediatric solid tumors, and nutrition in cancer patients.

Clinical Interests

Sarcomas, leukemia, nutrition in cancer patients, and rare pediatric tumors

Education

Medical School: 

University of Kentucky Medical School, Lexington, KY

Internship: 

University of Texas Southwestern Medical Center, Dallas, TX

Residency: 

University of Texas Southwestern Medical Center, Dallas, TX

Fellowship: 

University of Texas Southwestern Medical Center, Dallas, TX

Accomplishments

Certification: 

Board certified in Pediatric Hematology-Oncology, American Board of Pediatrics

Professional Memberships: 

Children's Oncology Group, American Society of Pediatric Hematology-Oncology

Awards: 

Best Doctors in America, 2007 to present

Publications: 

Subbiah V, Lamhamedi-Cherradi SE, Cuglievan B, Menegaz BA, Camacho P, Huh W, et al. Multimodal treatment of desmoplastic small round cell tumor: chemotherapy and complete cytoreductive surgery improve patient survival. Clin Canc Res 2018;24:4865-73. PMID: 29871905.

Joseph M, Hamilton E, Huh W, Hayes-Jordan A, and Austin A. The impact of racial/ethnic disparities on survival for children and young adults with chest wall sarcoma: a population-based study. J Pediatr Surg 2018;53:1621-26. PMID: 29729823.

Hayes-Jordan A, Coakley BA, Green HL, Xiao L, Fournier KF, Herzog CE, Ludwig JA, McAleer MF, Anderson PM, and Huh WW. Desmoplastic small round cell tumor treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results from a phase 2 trial. Ann Surg Oncol. 2018;25:872-77. PMID: 29383611.

Tarek N, Hayes-Jordan A, Salvador L, McAleer MF, Herzog CE, and Huh WW. Recurrent desmoplastic small round cell tumor responding to an mTOR-inhibitor containing regimen. Pediatric Blood Cancer 2018;65:e26768. PMID: 28941151.

Huh WW, Daw NC, Herzog CE, et al. Ewing sarcoma family of tumors (EFST) in children younger than 10 years of age. Pediatric Blood Cancer 2017;64:e26275. PMID: 27696711.

Research Interests: 

Nutrition in cancer patients

Research Focus/Overview

It is well known that cancer patients often experience weight loss due to inadequate intake and side effects from therapy, such as nausea or changes in taste. I am interested in developing a Nutrition Program that provides best available evidence-based education to patient families and serving as an academic research program to study areas such as food accessibility, micronutrient deficiences, and clinical outcomes based on nutritional status.

4650 Sunset Blvd.
MS #54
Los Angeles, CA 90027
Phone: 323-361-7964Office
Fax: 323-361-3837Fax